Categories
Health

New Rule Raises Query: Who’ll Pay for All of the Covid Checks?

Spurred by rising Covid cases and the Delta variant’s spread, a wave of major employers announced the same rule for unvaccinated workers this week: They will need to submit to regular surveillance testing. The new requirement raises a thorny question: Who pays for those coronavirus tests?

Doctors typically charge about $50 to $100 for the tests, so the costs of weekly testing could add up quickly. Federal law requires insurers to fully cover the tests when ordered by a health care provider, but routine workplace tests are exempt from that provision.

“It’s really up to the employer,” said Sabrina Corlette, a research professor at Georgetown University’s Center on Health Insurance Reforms. “They can require employees to pick up the tab.”

Employers have so far taken a range of approaches, from fully covering the costs to having unvaccinated workers pay full freight.

The U.S. government will pay for its unvaccinated workers’ coronavirus testing, Karine Jean-Pierre, the deputy White House press secretary, said at a news briefing Friday.

President Biden announced rules on Thursday that amount to a two-tier system for the country’s four million federal employees. Those who do not get vaccinated will have to social-distance, wear face coverings and comply with limits on official travel. Those who do get vaccinated will have no such requirements.

The unvaccinated will also have to submit to regular coronavirus testing. Each federal agency will come up with a plan for testing its unvaccinated work force. The costs and procedures of each agency’s testing protocols will depend on the number of unvaccinated people they need to monitor.

“The agencies are going to be implementing this program themselves, so they’ll be in charge of how that moves forward,” Ms. Jean-Pierre said.

Among the employers taking a different approach is Rhodes College in Tennessee: It will have unvaccinated students, faculty and staff pay a $1,500 fee per semester to cover the costs associated with a weekly coronavirus testing program.

Rhodes, a small liberal arts college, estimates that three-quarters of its employees are vaccinated. It is still collecting information about the vaccination rate among its 2,000 students, and it strongly encourages vaccination. But it is waiting until full Food and Drug Administration approval of the vaccines before mandating them.

Updated 

July 31, 2021, 11:42 a.m. ET

“This is not a punishment,” said Meghan Harte Weyant, the college’s vice president for student life. “For students who choose to return to campus unvaccinated, they will have to cover their costs. This is intended to ensure that students who are vaccinated do not have to bear that cost.”

Other employers are having workers chip in for the costs of coronavirus testing. MGM Resorts, which owns many hotels and casinos in Las Vegas, will charge a $15 co-pay for the testing at an on-site clinic for unvaccinated workers, multiple news outlets reported last week. Workers will also have the option to be tested at an outside provider.

MGM Resorts did not respond to a New York Times request for comment on the new policy.

These disparate approaches could provide a menu of options for workplaces still deciding who will pay for unvaccinated workers’ coronavirus tests, and how much.

New York and California started testing requirements for unvaccinated state workers this week, but neither has specified who will pay for the service. Neither governor’s press office responded to a Times request for comment.

Many states and cities still have free coronavirus testing sites that they started earlier in the pandemic. Long Beach, Calif., announced this week that it would require testing for unvaccinated city workers. In a statement to The Times on the new rule, the city said that workers “will have the option to do their mandated testing for free at the Long Beach Health Department” when the requirement takes effect in mid-August.

But many Americans also get tests at doctor’s offices and pharmacies, which will typically bill patients and their insurance for the service.

Understand the State of Vaccine Mandates in the U.S.

Federal law requires insurers to fully cover coronavirus tests ordered by health care providers, meaning the doctor cannot apply a deductible or co-payment to the service. Rules written by the Trump administration, and continued into the Biden administration, excluded routine workplace testing from that requirement.

In practice, insurers do often end up covering employer-mandated tests — it’s hard to tell from a doctor’s bill whether a workplace ordered the care — but they could start reviewing cases of patients who suddenly have claims every week for the same service.

“If they are starting to see a significant number of people who have these tests submitted every week, or twice a week, under federal law they would be within their authority to say this looks like routine workplace testing and not cover it,” said Professor Corlette of Georgetown.

This means unvaccinated workers who have to obtain their own coronavirus testing could have to pay their own fees. Some patients have faced surprise medical bills for coronavirus tests, which can range from a few dollars to over $1,000.

Some of those bills were the result of an employer-mandated test. In the last year, The Times has asked readers to send in their medical bills for coronavirus testing and treatment, and reviewed multiple cases of surprise charges for a workplace-required test.

That includes Marta Bartan, who needed a coronavirus test to return to a job last summer working as a hair colorist in Brooklyn. As The Times reported, she received a $1,394 bill from a hospital running a drive-through site.

“I was so confused,” she said at the time. “You go in to get a Covid test expecting it to be free. What could they have possibly charged me $1,400 for?”

Categories
Health

New Rule Raises Query: Who’ll Pay for All of the Covid Checks?

Spurred by rising Covid cases and the Delta variant’s spread, a wave of major employers announced the same rule for unvaccinated workers this week: They will need to submit to regular surveillance testing. The new requirement raises a thorny question: Who pays for those coronavirus tests?

Doctors typically charge about $50 to $100 for the tests, so the costs of weekly testing could add up quickly. Federal law requires insurers to fully cover the tests when ordered by a health care provider, but routine workplace tests are exempt from that provision.

“It’s really up to the employer,” said Sabrina Corlette, a research professor at Georgetown University’s Center on Health Insurance Reforms. “They can require employees to pick up the tab.”

Employers have so far taken a range of approaches, from fully covering the costs to having unvaccinated workers pay full freight.

The U.S. government will pay for its unvaccinated workers’ coronavirus testing, Karine Jean-Pierre, the deputy White House press secretary, said at a news briefing Friday.

President Biden announced rules on Thursday that amount to a two-tier system for the country’s four million federal employees. Those who do not get vaccinated will have to social-distance, wear face coverings and comply with limits on official travel. Those who do get vaccinated will have no such requirements.

The unvaccinated will also have to submit to regular coronavirus testing. Each federal agency will come up with a plan for testing its unvaccinated work force. The costs and procedures of each agency’s testing protocols will depend on the number of unvaccinated people they need to monitor.

“The agencies are going to be implementing this program themselves, so they’ll be in charge of how that moves forward,” Ms. Jean-Pierre said.

Among the employers taking a different approach is Rhodes College in Tennessee: It will have unvaccinated students, faculty and staff pay a $1,500 fee per semester to cover the costs associated with a weekly coronavirus testing program.

Rhodes, a small liberal arts college, estimates that three-quarters of its employees are vaccinated. It is still collecting information about the vaccination rate among its 2,000 students, and it strongly encourages vaccination. But it is waiting until full Food and Drug Administration approval of the vaccines before mandating them.

Updated 

July 30, 2021, 7:36 p.m. ET

“This is not a punishment,” said Meghan Harte Weyant, the college’s vice president for student life. “For students who choose to return to campus unvaccinated, they will have to cover their costs. This is intended to ensure that students who are vaccinated do not have to bear that cost.”

Other employers are having workers chip in for the costs of coronavirus testing. MGM Resorts, which owns many hotels and casinos in Las Vegas, will charge a $15 co-pay for the testing at an on-site clinic for unvaccinated workers, multiple news outlets reported last week. Workers will also have the option to be tested at an outside provider.

MGM Resorts did not respond to a New York Times request for comment on the new policy.

These disparate approaches could provide a menu of options for workplaces still deciding who will pay for unvaccinated workers’ coronavirus tests, and how much.

New York and California started testing requirements for unvaccinated state workers this week, but neither has specified who will pay for the service. Neither governor’s press office responded to a Times request for comment.

Many states and cities still have free coronavirus testing sites that they started earlier in the pandemic. Long Beach, Calif., announced this week that it would require testing for unvaccinated city workers. In a statement to The Times on the new rule, the city said that workers “will have the option to do their mandated testing for free at the Long Beach Health Department” when the requirement takes effect in mid-August.

But many Americans also get tests at doctor’s offices and pharmacies, which will typically bill patients and their insurance for the service.

Understand the State of Vaccine Mandates in the U.S.

Federal law requires insurers to fully cover coronavirus tests ordered by health care providers, meaning the doctor cannot apply a deductible or co-payment to the service. Rules written by the Trump administration, and continued into the Biden administration, excluded routine workplace testing from that requirement.

In practice, insurers do often end up covering employer-mandated tests — it’s hard to tell from a doctor’s bill whether a workplace ordered the care — but they could start reviewing cases of patients who suddenly have claims every week for the same service.

“If they are starting to see a significant number of people who have these tests submitted every week, or twice a week, under federal law they would be within their authority to say this looks like routine workplace testing and not cover it,” said Professor Corlette of Georgetown.

This means unvaccinated workers who have to obtain their own coronavirus testing could have to pay their own fees. Some patients have faced surprise medical bills for coronavirus tests, which can range from a few dollars to over $1,000.

Some of those bills were the result of an employer-mandated test. In the last year, The Times has asked readers to send in their medical bills for coronavirus testing and treatment, and reviewed multiple cases of surprise charges for a workplace-required test.

That includes Marta Bartan, who needed a coronavirus test to return to a job last summer working as a hair colorist in Brooklyn. As The Times reported, she received a $1,394 bill from a hospital running a drive-through site.

“I was so confused,” she said at the time. “You go in to get a Covid test expecting it to be free. What could they have possibly charged me $1,400 for?”

Categories
World News

Walmart’s Indian e-commerce retailer Flipkart raises $3.6 billion

Workers unload rice bags at a grocery store known as Kirana in Bengaluru, India on Monday June 21, 2021. D.

Dhiraj Singh | Bloomberg | Getty Images

India’s e-commerce giant Flipkart said Monday it had raised $ 3.6 billion in fresh funds from global investors including sovereign wealth funds, private equity and its parent company Walmart.

The new round of funding was led by the Singapore sovereign wealth fund GIC, the Canada Pension Plan Investment Board, SoftBank Vision Fund 2 and Walmart. It also included investments from sovereign wealth funds such as Qatar Investment Authority, Khazanah Nasional Berhad from Malaysia and DisruptAD, the venture arm of the Abu Dhabi sovereign wealth fund, ADQ.

Other donors included Tencent from China, Franklin Templeton and Tiger Global.

“This investment by leading global investors reflects the promise of digital commerce in India and their belief in Flipkart’s ability to maximize that potential for everyone involved,” said Kalyan Krishnamurthy, CEO of Flipkart, in a statement.

He said the company will focus on helping millions of Indian small and medium-sized businesses grow, including small family-owned grocery stores known as kiranas, and plans to continue investing in new categories and domestic technology.

SoftBank’s return

Japan-based SoftBank had previously sold its Flipkart stake to Walmart in 2018, and their return comes at a time when the Indian company is reportedly considering potential stock exchange options. Flipkart said it now has a valuation of $ 37.6 billion.

SoftBank has supported other Indian tech startups, such as digital payments company Paytm, budget hotel room start-up Oyo and ride-sharing company Ola.

“SoftBank’s re-investment in Flipkart is driven by our experience and the belief of the company’s management team to continue serving the needs of Indian consumers for decades to come,” said Lydia Jett, partner at SoftBank Investment Advisers, in a statement.

India’s e-commerce potential

Most of the retail business in India takes place in brick and mortar stores, but the online the potential remains enormous: India has one of the fastest growing and largest internet populations in the world.

In recent years, a combination of reforms, a push toward digitization, and last year’s coronavirus pandemic – and subsequent national and regional lockdowns – has shifted some of the transactions online.

In the last three months of 2020, India’s e-commerce sector grew 36% in volume and 30% in value year-over-year, according to a joint report by Unicommerce and Kearney.

The personal care, beauty and wellness category grew 95% year-over-year, while consumer goods and health care grew 46%. According to the report, most of the incremental growth was driven by sharp spikes in e-commerce volume and value in India’s tier 2 and tier 3 cities.

Flipkart’s competitors include US e-commerce giant Amazon, which has invested billions of dollars in the Indian market, as well as local names like JioMart, Reliance Industries’ online grocery delivery app.

For its part, the Indian government reportedly proposed new draft e-commerce rules in June that are expected to affect Flipkart and Amazon India.

Categories
Health

Delta Plus, a New Variant, Raises Considerations in India

As India reopens after a devastating second wave of coronavirus infections, virologists worry that another, potentially more virulent version of the virus could accelerate the onset of a third wave within a few months.

The version known locally as Delta Plus is described by scientists as a sub-line of the highly contagious Delta variant, which has quickly spread to India, the UK, the US, and other countries. The new variant carries a spike protein mutation, which can also be found in the beta variant, which was first identified in South Africa, although it is unclear how this common mutation could affect the function of the variant.

Reports suggest that cases of Delta Plus have been found in nearly a dozen countries, including the United States. In India, Delta Plus was first detected in April in the western state of Maharashtra. Authorities in India this week declared it a new “worrying variant” in the country after finding more than 40 cases in three states: Maharashtra, Madhya Pradesh and Kerala.

The Indian Ministry of Health announced this week that Delta Plus has shown increased portability. States where the variant was found have been asked to step up testing, improve surveillance, and speed up contact tracing to try to prevent it from spreading.

Due to its recent discovery, studies of this particular variant have not yet been carried out, so scientists have limited information. However, they have begun to speculate about their ability to spread.

“It is most likely able to evade immunities,” said Shahid Jameel, virologist and director of the Trivedi School of Biosciences at Ashoka University in Sonipat, India. “That’s because it carries all of the symptoms of the original Delta variant as well as its partner beta variant.”

Indian Health Ministry officials stressed that both Covid vaccines that are widely used in the country – the AstraZeneca vaccine made by the Serum Institute of India and the Covaxin vaccine made by Indian company Bharat Biotech – are likely to be effective against variants, including Delta are pluses.

Understand the Covid crisis in India

India’s vaccination campaign picked up pace this week, with more than 6.7 million people vaccinated across the country on Thursday, according to official figures. Prime Minister Narendra Modi’s government has stated that the syringes should be offered free to all adults in support of vaccination efforts that have been hampered by mismanagement and lack of care. About 5.5 percent of the population are fully vaccinated, and 18 percent have received at least one vaccination.

In Maharashtra, one of the hardest hit states, officials said Delta Plus was becoming a significant problem and warned that if cases increased, they would reintroduce restrictions.

“We are at the end of a second wave and will be careful how we unlock,” said Rajesh Tope, the country’s health minister. “The lessons we learned from dealing with the second wave are used to stop the spread of any new variant.”

Delta Plus was also identified this month by UK health officials calling it Delta-AY.1. They wrote in a June 11 report that they had discovered 36 cases, the first five of which were contacts from people who had recently traveled through Nepal and Turkey. Half of the 36 cases occurred in people who were not vaccinated and none of the cases resulted in death, but the report warned that “limited epidemiological information” was available about the variant.

Categories
World News

Northvolt raises $2.75 billion from Goldman, VW to compete with Tesla

Northvolt’s battery factory in northern Sweden in June.

North volt

Northvolt, a Swedish battery maker, has raised $ 2.75 billion from a number of big names to fuel its global expansion and increase production.

Headquartered in Stockholm, the company makes the lithium-ion batteries used to power electric cars, and claims it has signed $ 27 billion in contracts with companies like BMW and VW. The aim is to manufacture “the most environmentally friendly batteries in the world” using renewable energy sources and recycled raw materials.

The latest funding round, Northvolt’s largest to date, was led by Goldman Sachs and VW alongside new investors including Swedish pension funds AP1, AP2, AP3, AP4 and Canadian pension provider OMERS. Previous investors such as Spotify CEO Daniel Ek and the investment company Baillie Gifford are also investing in the round.

The total investment in the company now stands at $ 6.5 billion. The latest round of funding valued Northvolt at $ 11.75 billion, according to a person familiar with the company who asked to remain anonymous as Northvolt did not publicly disclose the number.

Northvolt was founded in 2016 and intends to use the financing to expand the capacity of its plant in the far north of Sweden from 40 gigawatt hours to 60 gigawatt hours, which is enough to supply batteries for around 1 million electric vehicles. Production is scheduled to start at the factory this year.

Read more about electric vehicles from CNBC Pro

Northvolt co-founder and CEO Peter Carlsson told CNBC in an interview on Wednesday that the company is making “fairly significant shipments” from a smaller facility that has been in operation for over a year to customers who are now doing their own business. Validations. “

While none of the company’s batteries are in electric vehicles that are on the road today, they are used on test tracks, Carlsson said, adding that he expects Northvolt’s batteries to be delivered in vehicles from 2023 and in energy storage applications by the end of the next year.

VW, which placed a $ 14 billion contract with Northvolt earlier this year, announced Wednesday that it had invested $ 500 million ($ 609 million) of the $ 2.75 billion and that its 20% stake in the company remains unchanged.

“With this investment, we are strengthening our strategic partnership with Northvolt as a supplier of sustainable battery cells that are manufactured with renewable energies and are comprehensively recyclable,” said Arno Antlitz, Group Board Member for Finance and IT at VW.

Michael Bruun, EMEA Head of Private Equity at Goldman Sachs Asset Management, told CNBC: “Northvolt’s green battery production and partnership with leading European automotive OEMs will be critical to enabling the energy transition in Europe, and the additional capital raised can accelerate the implementation of the company. “

Northvolt batteries are based on “a different chemistry” than Tesla’s and performance is becoming increasingly similar, said Carlsson, who was Tesla’s vice president of supply chain in Palo Alto between 2011 and 2015.

Making the batteries sustainable is one of Northvolt’s biggest challenges, he added. If the world switched to electric vehicles powered by batteries from coal-based economies like China, it would create a new carbon footprint the size of Spain, Carlsson said. “If we do this on the basis of renewable energy … we can prevent this from happening,” he said.

The company’s main plant is in Sweden and is considering building a second in Germany if enough renewable energy sources are available.

By 2030, the aim is to achieve 150 gigawatt hours of used annual production capacity in Europe.

Categories
Politics

Democratic Report Raises 2022 Alarms on Messaging and Voter Outreach

The Democrats defeated President Donald J. Trump and captured the Senate last year with a racially diverse coalition that has won tiny margins in key states like Georgia, Arizona and Wisconsin.

They cannot expect to repeat this feat in the next elections, warns a new report.

A 2020 election review conducted by several prominent Democratic pressure groups found that the party is at risk of losing ground with Black, Hispanic, and Asian-American voters if it does not do a better job of delivering an economic agenda present and counter efforts by Republicans to spread misinformation and bind all Democratic candidates to the far left.

The 70-page report submitted to the New York Times was compiled at the behest of three major democratic pressure groups: Third Way, a centrist think tank, and the Collective PAC and Latino Victory Fund, which sponsor black and Hispanic candidates. It seems like the most thorough act of self-criticism by either Democrats or Republicans since the last election campaign.

The document is all the more eye-catching as it is addressed to a victorious party: despite their successes, the Democrats had hoped to gain more robust control over both houses of Congress, rather than the extremely precarious margins they enjoy.

The study found, in part, that Democrats fell short of their ambitions because many House and Senate candidates failed to garner Joseph R. Biden Jr.’s support with colored voters who loathed Mr. Trump but distrusted the Democratic Party as a whole. These constituencies included Hispanic voters in Florida and Texas, Vietnamese-American and Filipino-American voters in California, and black voters in North Carolina.

Overall, the report warns, in 2020 the Democrats lacked a core argument about the economy and recovery from the coronavirus pandemic – one that might have helped candidates fend off Republican claims they wanted to “shut down the economy” or worse. The party “relied too heavily on ‘anti-Trump’ rhetoric,” the report concludes.

“Winning or losing, whether they call themselves progressive or moderate, Democrats consistently cited the Democratic Party’s lack of a strong brand as a major concern in 2020,” the report said. “In the absence of strong party branding, the opposition clung to the GOP’s talking points and suggested that our candidates would ‘burn your house down and take the police away.'”

Former MP Debbie Mucarsel-Powell, a Democrat who lost re-election in South Florida in November, said in an interview that she spoke with the report’s authors and raised concerns about the Democrats’ reach towards Hispanic voters and the party’s failure to misinformation refute, voiced in Spanish-language media.

“Unfortunately, in a way, the Democratic Party has lost touch with our electorate,” said Ms. Mucarsel-Powell. “There is this assumption that naturally colored people or the working class will vote for Democrats. We can never accept anything. “

Drafted primarily by two veteran Democratic activists, Marlon Marshall and Lynda Tran, the report is one of the most significant volleys in the Democratic Party’s internal debate on how to approach the 2022 elections. It may arouse skepticism from some quarters because it involves the Third Way, which many on the left view with hostility.

A fourth group that originally supported the study, the campaign finance reform group, End Citizens United, withdrew this spring. Tiffany Muller, the group’s head, said she needed to give up her involvement and instead focus on passing the For the People Act, a comprehensive good government bill stuck in the Senate.

Mr. Marshall and Ms. Tran, as well as the groups supporting the review, have in the past few days started sharing their conclusions with Democratic lawmakers and party officials, including Jaime Harrison, chairman of the Democratic National Committee.

The study spanned nearly six months of research and data analysis, examining about three dozen races for the House and Senate, and included interviews with 143 people, including lawmakers, candidates and pollsters, said people involved in compiling the report . Campaigns reviewed included Senate elections in Arizona, Georgia, and North Carolina, and house races in the suburbs of Minneapolis, Los Angeles, Atlanta, and Dallas, and in rural New Mexico and Maine.

The study follows an internal review conducted by the Democratic Congress Election Committee and presented last month. Both projects found that democratic candidates had been hampered by flawed polls and campaign restrictions imposed by a pandemic.

In the DCCC report, the committee attributed setbacks at the congressional level to a surge in voter turnout by Trump supporters and an inadequate response by Democrats to attacks they labeled police-hating socialists.

Some MPs on the left have complained that criticism of left-wing embassies amounts to scapegoating activists for the party’s failure.

But the review of Third Way, the Collective PAC, and the Latino Victory Fund goes further, diagnosing the party’s message as flawed, which may have cost the Democrats more than a dozen House seats. The report offers a blunt assessment that in 2020 Republicans succeeded in deceiving voters about the Democrats’ agenda and that Democrats made a mistake by speaking to colored voters as if they were a monolithic, left-wing group.

California MP Tony Cárdenas, who heads the Congressional Hispanic Caucus Political Action Committee, welcomed this criticism of Democratic embassies and said the party should abandon the assumption that “colored voters are inherently more progressive.”

“That was a ridiculous idea, and it was never true,” said Cárdenas, lamenting that Republicans had “managed to confuse Latino voters with the message of socialism, things like that, ‘to disappoint the police.”

Quentin James, president of the Collective PAC, said it was clear that “some of the rhetoric we see from the Coast Democrats” has been problematic. Mr James pointed to activists’ demands to “discover” the police as being particularly harmful, even when it comes to overhauling the police.

“We conducted a poll that showed that, by and large, black voters were very supportive of police reform and budget reallocation,” said James. “That terminology – ‘defund’ – was not popular in the black community.”

Kara Eastman, a progressive Democrat who lost her bid for a seat in the House of Representatives based in Omaha, said Republicans had managed to deliver a “message of messages” that deceived her and her party as out of the mainstream. Ms. Eastman said she told the 2020 review authors that she believed these labels were particularly harmful to women.

Third Way strategist Matt Bennett said the party needed to be much better prepared to build a defense in the mid-term campaign.

“We have to take these attacks on Democrats as radicals very seriously and make them land,” said Bennett. “A lot of it just didn’t end up with Joe Biden.”

The Democrats retained a big advantage with black voters in the 2020 election, but the report identified clear weaknesses. Mr Biden and other Democrats lost ground among Latino voters compared to the party’s 2016 performance, “especially among working-class and non-college voters in these communities,” the report said.

The report found that a surge in Asian-American voter turnout had apparently secured Mr. Biden’s victory in Georgia, but that Democratic House candidates ran behind Mr. Biden with Asian-American voters in competitive races in California and Texas. In some key states, the Democrats did not mobilize black voters as much as the Republicans did to mobilize conservative white voters.

“A significant increase in voter turnout earned Democrats more raw votes from black voters than in 2016, but explosive growth among white voters in most races exceeded those increases,” the report warns.

On the Republican side, there has been no comparable self-assessment following the party’s severe setbacks last year, mainly because GOP leaders are reluctant to debate the impact of Mr Trump.

The Republican Party faces serious political obstacles resulting from Mr Trump’s unpopularity, the growing liberalism of young voters, and the country’s growing diversity. Many of the party’s policies are unpopular, including cuts in social and pension programs and lower taxes for the wealthy and large corporations.

Yet the structure of the American electoral system has tilted national campaigns in the direction of the GOP because of gerrymandering in Congress and the disproportionate representation of rural whites in the Senate and electoral college.

Democrats’ hopes for the mid-term election so far have depended on the prospect of a strong recovery from the coronavirus pandemic and on voters seeing Republicans as an unfit party.

New Jersey MP Mikie Sherrill, a moderate Democrat who was briefed on the report’s findings, called it evidence that the party needs a strong central message about the economy in 2022.

“We need to keep showing the American people what we’ve done and then talk ceaselessly across the country and in every city about how the Democrats run,” Sherrill said.

The report largely ignores the immense Democrats’ deficit among lower-income white voters. In their conclusion, however, Mr. Marshall and Ms. Tran write that the Democrats must deliver a message that includes working class whites and is in line with the GOP’s clear “collective gospel” on low taxes and military strength.

“Our gospel should be to stand up for all working people – including, but not limited to, white working people – and to enhance our values ​​of opportunity, equality and inclusion,” they write.

Categories
Business

O.E.C.D. Raises International Progress Forecast Sharply, Citing Vaccines

The global economy is expected to recover from the coronavirus pandemic faster than expected this year, as vaccinations in advanced economies and an enormous fiscal stimulus package in the United States unleash pent-up business activity and job creation, the Organization for Economic Cooperation and Development said on Monday.

But the pace of the recovery still hinges on vaccination programs and the ability of governments to beat back new variants of the virus, raising fresh risks even as economic activity starts to rev back up in most parts of the world, the organization said in its latest economic outlook.

The organization sharply raised its forecast for global growth to 5.8 percent in 2021, up from a 4.2 percent projection in December. It said the pace of expansion would cool to 4.5 percent in 2022 as government support programs unwind.

A government stimulus-led upturn in the United States, where President Biden is betting on a $2 trillion infrastructure package to end the effects of the pandemic faster, has helped improve the global outlook, the group said. China continues to experience the world’s strongest rebound, also lifting the global outlook.

In Europe, which has been lagging the United States in a recovery, an acceleration of vaccination programs has allowed governments to begin lifting restrictions on activities, speeding up what had been a slow economic reopening.

The opposite is true for many emerging-market economies that are suffering from slow distribution of vaccines, new outbreaks of Covid-19 and economically limiting containment measures, dampening prospects for a quick recovery.

India, which has suffered a deadly resurgence of the virus, is likely to face economic struggles as a result and a slower return to prepandemic growth levels until the impact of the virus fades, the organization said.

It estimated the economy in the United States would grow 6.9 percent in 2021; in China, 8.5 percent; in the euro area, 4.3 percent; in Britain, 7.2 percent; in Argentina, 6.1 percent; and in India, 9.9 percent.

“Our latest projections provide hope that in many countries, people hit hard by the pandemic may soon be able to return to work and start living a normal life again,” Laurence Boone, the organization’s chief economist, said during a news briefing.

“But we are at a critical stage of the recovery. Vaccination production and distribution have to accelerate globally and be backed by effective public health strategies,” she said.

Categories
Health

Ada Well being raises money from Samsung and Bayer for A.I. physician app

Berlin-based company Ada Health, which developed a doctor-style app that uses artificial intelligence to diagnose symptoms, was supported by the investment arms of South Korean company Samsung and German pharmaceutical giant Bayer.

Ada Health announced Thursday that it has initiated a $ 90 million round of funding with an undisclosed valuation that brings the total investment in the company to approximately $ 150 million.

Bayer led the round through its Leaps by Bayer investment arm, while Samsung invested through the Samsung Catalyst Fund, a US-based venture capital fund that Samsung Electronics uses to support companies worldwide. Young Sohn, former chief strategy officer and corporate president of Samsung Electronics, has joined the board of directors of Ada Health.

Ada Health was founded in 2011 by entrepreneurs Dr. Claire Novorol, Martin Hirsch and Daniel Nathrath and states that the app has been downloaded over 11 million times.

How it works

“The app works basically like a WhatsApp chat with your trusted family doctor, but around the clock,” CEO Nathrath told CNBC.

The patient starts typing in their symptoms and an AI chat bot asks a series of questions to help pinpoint the problem. After that, the app will show the patient the conditions that are most likely the cause and offer some suggestions on what to do next to fix the problem.

The iOS and Android apps provide general information on how to see a family doctor in the next three days. However, when patients interact with Ada Health through a healthcare system that uses the app, they can book an appointment directly and share the result of their preliminary exam with a real doctor, Nathrath said.

He said the company has signed contracts with multiple health systems, health insurers, and life science companies. Axa OneHealth, Novartis, Pfizer and SutterHealth are listed as partners on the Ada Health website.

While the app can be downloaded free of charge for patients, Ada Health charges its partners for access to the software.

The company said the new funds will be used to expand deeper into the US, which is already the largest market with 2 million users. Elsewhere, Ada Health has around 4 million users in the UK, Germany, Brazil and India with around 1 million each.

The funds will also be used to improve the company’s algorithms, expand the medical knowledge base, and go beyond 10 languages, Nathrath said.

He also wants to provide the Ada Health app with additional information beyond the symptom data provided by the patient. That could include lab data, genetic testing, and sensor data, Nathrath said.

“Smartwatches and other sensors have really made a big leap forward,” said Nathrath. “Nowadays you can measure your blood pressure, do an EKG, measure heart rate variability and blood oxygen levels.”

“Our goal is really to develop what is known as a personal operating system for health, in which you can not only carry out a symptom check, but also integrate all relevant sources of health information in such a way that Ada can ideally become this companion and notify you before the pound 100 problem is becoming a pound 100,000 problem a year. “

U-turn on tele health

Ada Health received less money than other “doctor” apps like Babylon and Kry.

Unlike Babylon and Kry, Ada Health does not allow patients to video call a family doctor.

Ada briefly ran a service called Doctor Chat, which allowed users to consult a registered GP through an on-demand chat portal. However, it was deactivated in March 2018 after having lived for about a year.

“We expected a lot more people to actually use this than they did,” said Nathrath, adding that people would prefer the automated chat experience to video calling with family doctors.

“If you look at telemedicine, you can’t scale it as well as an AI solution because you still have to hire a lot of doctors in different countries,” said Nathrath.

The investment in Ada Health comes just over two weeks after British health start-up Huma raised $ 130 million from the venture arms of Bayer, Samsung and Hitachi.

Other investors in the last round of Ada Health are Vitruvian Ventures, Inteligo Bank, F4 and Mutschler Ventures.

Categories
Health

UK well being startup Huma raises $130 million from traders

Dan Vahdat, CEO and Co-Founder of Huma.

you are

LONDON – The coronavirus pandemic has accelerated the shift towards digital health services and investors are keen to capitalize on the trend by making big stakes in space.

In the UK, London-based Huma announced Wednesday that it had raised $ 130 million in an investment round led by Bayer and Hitachi’s corporate venture arms. The cash injection was also supported by Samsung, Sony and Unilever mutual funds.

Founded in 2011 as Medopad, Humas Software enables clinicians to remotely monitor patients via a mobile app. It also uses a number of wearables and other devices to collect data on things like heart rate and oxygen saturation. The startup claims it is able to detect worsening patients’ health and decide whether or not to go to the hospital.

The company works with the UK National Health Service and governments in Germany and the United Arab Emirates. Dan Vahdat, CEO and co-founder of Huma, said the company offered its services to the NHS on a pro bono basis during the Covid-19 crisis.

“Last year we committed to caring for Covid patients free of charge,” Vahdat told CNBC in an interview. “We thought that was the right thing to do. We are very fortunate to have long-term, visionary investors to support us.”

Huma claims to have doubled the capacity or reach in some of the hospitals it works with in the UK by allowing clinicians to see twice as many patients as they normally would thanks to its “Hospital at Home” service. It is also said to have succeeded in reducing hospital admissions by a third.

According to results released by the National Health Service’s innovation arm, NHSX, doctors in London were able to support an average of 20 patients per hour with Huma, up from 12 patients per hour for employees who do not use the company’s technology. Using Huma also saved about 3 minutes less time that doctors would normally spend with patients.

In Germany, the company signed a contract with the government to buy pulse oximeters – which measure oxygen saturation – from Amazon. Huma insists that the work in support of governments’ pandemic responses is not for profit and that it has signed procurement agreements with health officials to help cover the costs.

Huma’s most recent round of funding gives the company the opportunity to raise an additional $ 70 million at a later date. Should it choose to do so, it would bring its valuation above $ 1 billion and give it “unicorn” status, said a person familiar with the matter, who preferred to remain anonymous as the information failed were released to CNBC.

This is the latest sign of investor confidence in the fast-growing digital healthcare industry. Last month, Swedish telemedicine startup Kry announced it had raised $ 300 million in a round to value the company at $ 2 billion.

A clinician uses the digital platform of the British healthcare start-up Huma.

you are

“The industry has already moved towards digital as a whole – the pandemic has accelerated it,” Vahdat said.

Huma, which has 125 employees according to LinkedIn, is still severely loss making. Vahdat says it is prioritizing growth for now.

“For us as a company, our vision is how we can most effectively influence the lives of people around the world so that everyone can live longer and fuller lives,” he said. “We believe that if we can achieve that vision, the money will take care of itself.”

Huma lost £ 11.6 million ($ 16.4 million) on 2019 sales of £ 5.4 million, according to a news from Companies House. However, sales grew more than 3,600% from the £ 146,000 reported in 2018. The group’s 2020 annual financial statements should be presented by September.

Although the company raised a sizable amount of money, Vahdat said the company still had most of the money in the bank from its last round in 2019. The company’s recent capital injection is aimed at building partnerships with companies like Bayer and expanding into markets like the US, Asia and the Middle East.

“We’re doing bigger projects with multinationals and governments,” said Vahdat. “Having a great track record helps us give them the confidence and potentially a better and more effective long-term partnership with some of our partners.”

Goldman Sachs acted as lead placement agent for Huma on the deal, while HSBC and Nomura acted as joint placement agents. Nomura is now also a shareholder in the company, said Huma.

Categories
Politics

Biden, in Reversal, Raises Refugee Cap to 62,500 in Subsequent 6 Months

President Biden turned on Monday and said he would allow up to 62,500 refugees to enter the United States over the next six months, removing the sharp limits that former President Donald J. Trump had placed on those seeking refuge before war, violence or nature seek disasters.

“This erases the historically low number set by the previous administration of 15,000 that does not reflect America’s values ​​as a nation that welcomes and supports refugees,” Biden said in a White House statement.

The action came about two weeks after Mr Biden announced he would keep Mr Trump’s line of 15,000 refugees. The announcement was widely condemned by Democratic lawmakers on Capitol Hill and refugee lawyers who accused the president of failing to keep an election promise to admit the needy.

White House officials had insisted that Mr Biden’s intentions were misunderstood in mid-April. However, his decision to raise the refugee limit to 62,500 suggests that he felt pressure to act.

In his statement, Mr Biden admitted that the government is unlikely to relocate 62,500 refugees as the agencies suffered budget and staff cuts during Mr Trump’s tenure. Mr Biden did not say whether the government had already managed to take in the 15,000 refugees admitted by his predecessor.

“The sad truth is we won’t get 62,500 approvals this year,” he said. “We are working quickly to reverse the damage suffered over the past four years. It will take time, but this work is already under way. “